Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

hTERT, hTR and TERT promoter mutations as markers for urological cancers detection: A systematic review.

Urologic oncology - 1 Aug 2021

Morozov Andrey, Potoldykova Natalya, Chinenov Denis, Enikeev Mikhail, Glukhov Alexander, Shpikina Anastasia, Goryacheva Evgenia, Taratkin Mark, Malavaud Bernard, Enikeev Dmitry

Abstract excerpt

The clinical relevance of telomerase subunits (human reverse transcriptase - hTERT, and human telomerase RNA - hTR) and TERT promotor mutations as biomarkers in genitourinary cancers was reviewed through the systematic analysis of the current literature. We performed a systematic literature search using 2 databases (Medline and Scopus) over the past 20 years. Primary outcomes were sensitivity and specificity of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Promoter Regions, Genetic

Share to Telomerase

Share to Urologic Neoplasms

Source

Identifiers

PMID: 33676848
DOI: 10.1016/j.urolonc.2021.01.022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

hTERT, hTR and TERT promoter mutations as markers for urological cancers detection: A systematic review.PMID 33676848Read ↗

Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer.Semantic proximity Read ↗

Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancerSemantic proximity Read ↗

Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management.Semantic proximity Read ↗

Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers.Semantic proximity Read ↗

TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region.Semantic proximity Read ↗

Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study.Semantic proximity Read ↗

Urine Telomerase: An Important Marker in the Diagnosis of Bladder CancerSemantic proximity Read ↗

Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.Semantic proximity Read ↗

Diagnostic performance of Uromonitor and TERTpm ddPCR urine tests for the non-invasive detection of bladder cancer.Semantic proximity Read ↗

Emerging targets in upper tract urothelial carcinomas: the TERT gene.Semantic proximity Read ↗

Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancerSemantic proximity Read ↗

The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.